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Abstract
Low adiposity has been linked to elevated mortality from several causes including respirato-
ry disease. However, this could arise from confounding or reverse causality. We explore the
association between two measures of adiposity (BMI andWHR) with COPD in the British
Women’s Heart and Health Study including a detailed assessment of the potential for con-
founding and reverse causality for each adiposity measure. Low BMI was found to be asso-
ciated with increased COPD risk while lowWHR was not (OR = 2.2; 95% CI 1.3 – 3.1
versus OR = 1.2; 95% CI 0.7 – 1.6). Potential confounding variables (e.g. smoking) and
markers of ill-health (e.g. unintentional weight loss) were found to be higher in low BMI but
not in lowWHR. Women with low BMI have a detrimental profile across a broad range of
health markers compared to women with lowWHR, and women with lowWHR do not ap-
pear to have an elevated COPD risk, lending support to the hypothesis that WHR is a less
confounded measure of adiposity than BMI. Low adiposity does not in itself appear to in-
crease the risk of respiratory disease, and the apparent adverse consequences of low BMI
may be due to reverse causation and confounding.
Introduction
The epidemic of obesity that is sweeping high income countries and emerging in the more af-
fluent sections of middle and low income countries is expected to increase the burden of chron-
ic diseases and mortality. While there is little disagreement about the association between
increased obesity and mortality, the causal relationship between low adiposity and mortality is
much less clear. Determining the precise nature of the association between measures of
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adiposity and chronic diseases and hence the optimal level of adiposity is important for public
health. A recent meta-analysis found lowest mortality risk at intermediate adiposity (Body
Mass Index, BMI 25-<30; weight/height2) suggesting increased risk with lower adiposity [1].
Cause-specific analyses demonstrate that higher BMI is associated with higher risk of coronary
heart disease (CHD), stroke and diabetes, whilst low BMI is associated with increased risk of
respiratory disease, lung cancer and other smoking-related cancers [2]. Some commentators
have suggested that the elevated respiratory disease mortality at low BMI may be causal [3].
The nature of the association of adiposity with chronic diseases is influenced by differences
in the distribution of known confounders in different study populations, imperfect measure-
ment of known confounders (residual confounding), imperfect modelling of non-linear con-
founders, as well as the distribution of unmeasured confounders. Inverse mortality associations
at low BMI with COPD, lung cancer and upper aerodigestive cancer have been found to be
stronger in smokers, suggesting residual confounding by smoking intensity is likely [2]. Appar-
ent higher risk at low adiposity could also result from confounding due to underlying ill-health
in study populations (“reverse causality”). Meta-analysis are often limited in their ability to
make adjustments for confounders as they may not be measured in comparable ways or in suf-
ficient detail in all studies, and therefore must find a compromise measurement that can fit
across studies.
Different measures of adiposity such as waist circumference (WC) or waist-hip ratio
(WHR) may have different associations with health outcomes compared to BMI. For example,
in the context of cardiovascular disease WC and WHRmight better capture central adiposity
and therefore be stronger markers of risk [4–6] The European prospective study (EPIC) found
less marked upturns with low mortality for WC or WHR than BMI [7], while the Scottish
Health Survey found no upturn in mortality at lowWHR [8]. Furthermore amongst older peo-
ple increased mortality risk by WC has been shown within BMI categories.[9] It is unclear
whether such differences between adiposity measures reflect real differences in risk or arise
from differences in their associated confounding structures.
In this study we use data from the British Women’s Heart & Health Study (BWHHS) to ex-
plore in detail the nature of associations of two different measures of adiposity (BMI and
WHR) with COPD including a detailed exploration of the association with potential confound-
ers, biomarkers and markers of ill-health in order to highlight potential epidemiological pitfalls
in the association between low BMI and elevated mortality.
Materials and Methods
The BWHHS is a prospectively studied cohort study of 4,286 women aged between 60 and 79
at baseline from 23 towns across England, Wales and Scotland. Sampling procedure and data
collection for the BWHHS is described in detail elsewhere.[10] Baseline measurements were
taken in 1999–2000 with follow-up questionnaires in 2003, 2007 and 2010. Biomarkers were
measured at baseline interview. Deaths and CVD events have been prospectively studied via
the Data Linkage Service Health and Social Care Information Centre and biennial review of GP
record. Ethical approval for the British Women’s Heart and Health Study was obtained from
the London Medical Research and Ethics Committee (MREC) as well as the 23 local Research
and Ethics Committee in each of the 23 towns participating in the study (S1 Appendix). Writ-
ten informed consent was obtained from each participant in the study.
All variables included in these analyses were measured at baseline in 1999–2001.
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Measures of adiposity
Four approximately equally sized categories of BMI were derived for descriptive analyses:<24,
24–27, 27–30 and>30 kg/ m2. The smallest category was then further sub-divided into those
with a BMI<22kg/ m2 in order to reflect the extreme of the BMI distribution amongst which
all-cause mortality was found to be elevated by the Prospective Studies Collaboration.[2] 7.7%
of women had BMI<22kg/ m2. WHR was derived from the average of two measures of waist
circumference divided by the average of two measures of hip circumference, both measured in
millimetres. WHR categories were derived in the same way as the BMI categories, i.e. division
into quartiles with the smallest category subsequently further divided to include women with
lowest adiposity as indexed by WHR. Therefore WHR categories were defined as:<0.72, 0.72–
0.77, 0.77–0.81, 0.81–0.86 and>0.86. Women with BMI< 15 kg/m2 or>50 kg/ m2 and
women with WHR<0.6 or> 1.1 were excluded from analyses.[2] Women with both measures
of adiposity available were included in the analyses.
Outcomes
COPD was defined according to the GOLD stage 2 criteria for moderate COPD;[11] when a
woman’s FEV1 was found to be less than 70% of forced vital capacity (FVC), and forced expira-
tory volume in 1 second (FEV1) was less than 80% of the population predicted FEV1 adjusted
for the age sex and height. Lung function tests were carried out using a digital meter Vitalo-
graph. Women were required to perform a minimum of three reproducible FVC measures
(within 5% of maximum FVC produced). The output that produced the highest sum of FVC
and FEV1 were used in the analyses. Spirometric measurements fulfilled ATS/
ERS requirements.
The MRC dyspnea scale was used as additional measure of respiratory function.[12][13]
Women were considered to have symptoms of dyspnea if they reported usually bringing up
phlegm in the morning on most days in the winter for as much as 3 months and having had a
period of increased cough and phlegm in the past four years lasting for 3 weeks or more.
Confounders—smoking
Smoking behaviour was measured as never versus ex/current smokers (self-reports), and
amongst self-declared current smokers only cigarettes per day and plasma cotinine (ng/ml).
Confounders—other lifestyle
Life-course socioeconomic position (SEP) was scored on a scale 0 to 10; where a higher score
indicates more measures of socioeconomic deprivation across the life course as described pre-
viously.[14] Physical activity was measured as hours of moderate or vigorous activity per week
(excluding housework) based on questions from the EPIC Norfolk questionnaire,[15] and cate-
gorised into two hours per week or less versus more than two hours per week. Healthy diet de-
scribes at least three healthy diet choices (brown or wholemeal bread; soft margarine or low
calorie spreading fats; vegetable oil or olive oil cooking fats; semi-skimmed or skimmed milk).
Confounders—markers of ill-health
Unintentional weight loss is self-reported unintentional weight change in the last 4 years. Loco-
motor disability is defined as difficulty with any one of: going up or down stairs, bending
down, straightening up, keeping balance, going out of the house, walking 400 yards, and/or
three or more falls in the past 12 months.[16] EQ-5D is a standardized instrument for measur-
ing health-related quality of life;[17] EQ-5D utilities were calculated and the lowest third was
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considered to be low HR-QoL. Self-reported health was recorded and dichotomised into poor
versus fair good or excellent. Self-reported number of medications was dichotomised into
those taking multiple medications (two or more) versus only one or none.
Biomarkers
All biomarkers were measured from venous blood samples taken at baseline; details of mea-
surement procedures are reported elsewhere.[18, 19] Individual standardized summary scores
for inflammation and coagulation biomarkers were calculated as previously described in the
BWHHS, where higher scores indicate a higher load.[20]
Statistical analyses
Descriptive analyses with measures of adiposity
For each BMI andWHR category we estimated means (with 95% confidence intervals) for con-
tinuous outcomes and confounders, and percentages (with 95% confidence intervals) for bina-
ry outcomes and confounders using linear or logistic regression models. The goodness of fit
was assessed by residual plots; where logarithmic transformation improved the model fit geo-
metric means were calculated. Parameters were estimated using generalised estimating equa-
tion (GEE) to adjust the variances for clustering of women within GP practices in 23 towns.
Stratified and adjusted analyses
Age-adjusted mean COPD prevalence by anthropometric category was stratified by smoking
status (ever versus never). Then in a separate series of models mean COPD prevalence by an-
thropometric categories was adjusted by introducing age, lifestyle and socio-economic vari-
ables (SEP score, physical activity), markers of ill-health (unintended weight loss, locomotor
disability, medications and EQ5D score) incrementally. Continuous confounding variables
were centered at their respective means prior to inclusion in the adjusted models. For binary
confounding variables COPD risk in the baseline category was modelled.
Results
S1 Table shows the number and prevalence (binary variables) or mean and standard deviation
(continuous variables) for all variables. Of the 3906 women with available data, 717 (18.4%)
were classified as having moderate COPD according to the GOLD criteria. S2 Table shows the
distribution and categorisation of BMI and WHR in the BWHHS. S3 Table shows the cross-
tabulation of BMI andWHR categories. While many women were consistently extreme for
both measures, some were extreme for one measure but not the other, especially at the lower
end of the distributions; for example, only 21% of women with BMI<22 kg/ m2 also have
WHR<0.72. The correlation coefficient for the two anthropometric measures is 0.37 (95% CI
0.35–0.40). S4 Table shows the distribution of all variables according to COPD
diagnosis status.
Descriptive association with low BMI andWHR
For some measures, there was evidence for a difference in prevalence in the lowest BMI and
WHR exposure categories (COPD, dyspnea symptoms, % never smoked and unintended
weight loss) (Fig 1, S5 Table, S6 Table and S7 Table). COPD prevalence was higher amongst
those with the lowest BMI compared to those with lowest WHR (15.2%; 95% CI 9.8–20.6
amongst those with a WHR<0.72 compared to 33.6%; 95% CI 26.1–41.1 amongst those with a
BMI< 22kg/m2) (Fig 1A). Results for dyspnea symptoms were consistent with this.
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Fig 1. (A) Prevalence of COPD and symptoms of lung function by categories of BMI andWHR (lowest to highest). (B) Prevalence of smoking
measures by categories of BMI andWHR (lowest to highest). (C) Prevalence of markers of ill-health by categories of BMI andWHR (lowest to highest).
doi:10.1371/journal.pone.0115446.g001
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Women with the lowest BMI were less likely to be never smokers than women with lowest
WHR (WHR: 71.7%; 95% CI 65.9–77.6; BMI: 54.0%; 95% CI 46.4–61.5) (Fig 1B). Amongst
self-declared smokers, plasma cotinine levels, an indicator of smoking intensity, were higher
amongst women with low BMI (234.1 ng/ml; 95% CI 200.6–273.2) than lowWHR (174.3 ng/
ml; 95% CI 113.0–268.9). No clear differences were found between BMI and WHR for ciga-
rettes per day as a measure of smoking intensity.
There was some weak evidence for low physical activity being more common amongst
women with BMI<22kg/m2 compared to women with WHR<0.72 (20.0%; 95% CI 13.8–26.2
compared to 11.6%; 95% CI 8.1–15.0). Results also suggest healthy diet may be more common
amongst those with lowWHR compared to low BMI but it is not possible to rule out the role of
chance in these findings. No clear evidence for differences in life-course SEP by BMI andWHR
categories was observed (S1 Fig).
Of the measures of ill-health unintended weight loss was higher amongst those with the
lowest BMI compared to those with lowest WHR (BMI: 31.4%; 95% CI 26.0–35.7 versus WHR:
9.9%; 95% CI 6.1–13.8). There was weak evidence for worse health amongst women with low
BMI as more declared poor health compared to women with lowWHR (4.1%; 95% CI 1.7–6.5
compared to 1.1%; 95% CI 0.0–2.4). Results were directionally consistent for multiple medica-
tions, low EQ5D and locomotor disability although no strong evidence was observed for these
measures. Women in the lowest BMI category are as likely to report low health-related quality
of life as women with a BMI>27.
Inflammation and coagulation biomaker scores were both directionally higher for BMI in
the lowest exposure group compared to WHR, although it is not possible to exclude the role of
chance in these findings (S2 Fig).
In summary, women with low BMI are more likely to be diagnosed with COPD and report
dyspnea symptoms. They are more likely to report a spectrum of measures of ill-health, includ-
ing poor health and unintended weight, with weaker evidence for lower quality of life and tak-
ing more medications. In addition, they are more likely to report ever having smoked and have
higher smoking intensity among those women who currently smoke. There is weaker evidence
that women with low BMI may also have lower levels of physical activity and adverse inflam-
mation and coagulation biomarker profiles.
Adjustment
As expected, estimated age-adjusted prevalence of COPD was lower amongst never smokers in
all anthropometric categories (Fig 2). Prevalence of COPD was elevated amongst never smok-
ers in the lowest BMI group (26.1%; 95% CI 19.0–33.3) and is comparable to that of smokers
with 22<BMI<24 (25.4%; 95% CI 20.9–29.9). Prevalence of COPD was clearly higher for
smokers than non-smokers in all categories of WHR.
The effect of the incremental adjustment on COPD diagnosis by BMI category relative to
baseline 22<BMI<24 is illustrated in Fig 3 (S8 Table). The odds of COPD in the lowest BMI
category remained higher (OR = 2.2; 95% CI 1.3–3.1) compared to normal BMI even after full
adjustment for age, lifestyle and ill-health, although the point estimates did move closer to one
on adjustment. There was no evidence for elevated odds of COPD for any category of higher
BMI. Unlike BMI, there is no evidence for increased odds of COPD in the lowest WHR catego-
ry relative to the baseline 0.72<WHR<0.77 (OR = 1.2; 95% CI 0.7–1.6), but we found increas-
ing odds of COPD in the higher WHR categories.
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Discussion
Low BMI has previously been linked to elevated mortality from several causes including respi-
ratory disease and liver disease. In this paper we explored the characteristics of women with
Fig 2. Prevalence of COPD adjusted for age and stratified by smoking status.
doi:10.1371/journal.pone.0115446.g002
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low BMI and how they differ from women with higher BMI as well as women with lowWHR.
We found evidence to support a different shaped association with COPD for BMI compared to
Fig 3. Gradual adjustment of associations between COPD and adiposity by age, lifestyle and ill-
health.
doi:10.1371/journal.pone.0115446.g003
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WHR, with higher COPD risk observed amongst women with low BMI. Furthermore, analysis
of the distribution of several potential confounding variables suggested that these were distrib-
uted differently according to categories of BMI compared to categories of WHR, lending sup-
port to the hypothesis that low BMI—high mortality associations may be an artefact produced
by confounding and reverse causation.
Low BMI can be the result of favourable behaviours (such as good diet and high physical ac-
tivity) or it may a marker of underlying disease (wasting). Clearly each of these will be associat-
ed with very different characteristics and future health outcomes. Given the relatively older age
of women in the BWHHS (in common with many prospective cohorts), we hypothesized that
the majority of women with low BMI are likely to fall into the second category. In these analy-
ses we find support for the hypothesis that women with low BMI have a detrimental profile
across a broad range of health markers, including weight loss. Weight loss is a well-established
predictor of mortality in older populations;[21, 22] accelerating three years before death for
cancer and five years before cardiovascular deaths.[23] Weight loss can also be a symptom of
COPD.[24]
Unlike low BMI, women who have very lowWHR do not appear to have an elevated risk of
COPD. Furthermore, lowWHR appears to be less likely to be associated with the spectrum of
adverse lifestyle (smoking, low physical activity) and markers of ill-health. These findings lend
support to the hypothesis that WHR is a less confounded measure of adiposity than BMI. How-
ever, while results appear consistent across a broad range of measures, the relatively small
number of women with extremely low BMI and WHR means our results are imprecise and re-
quire replication in other studies. Different shaped functions for the association between an-
thropometric measures and mortality have previously been reported, with less marked upturn
at the lower end of the distribution for WHR and WC [7]. The Emerging Risk Factors collabo-
ration also report a J-shaped association between BMI and coronary heart disease, but a linear
association for WC andWHR.[25]
These findings have important implications for epidemiological studies seeking to reveal the
true association between adiposity and disease outcomes. Conventional adjustment for vari-
ables such as smoking (current, ex-, never) is unlikely to be adequate to remove the residual
confounding effects of smoking intensity.[26] We find that the association between low BMI
and COPD is relatively unaffected by adjustment for the life-style variables and markers of ill-
health available in the BWHHS with a strong association remaining. Again, this suggests that
residual confounding, both from lifestyle factors and ill-health (“reverse causation”), may re-
main as important limitations in epidemiological studies which often adjust for far fewer vari-
ables. Furthermore, while studies may exclude the first years of follow-up (commonly five) this
is unlikely to be sufficient to remove the potential effect of COPD on weight loss given that its
onset is gradual and progressive over many years.[27] The problem of reverse causality in ob-
servational studies has recently been highlighted in a large Chinese study showing that even in
participants “apparently free” from disease at baseline the mortality hazard ratio for low BMI is
substantially stronger in those who die in the first five years [28]. Indirect markers of BMI
(childhood BMI [29], offspring BMI[30], or genetic variants associated with adiposity[31])
may therefore be helpful to understand the nature of the associations of low BMI with the in-
creased risk of some diseases since they minimise the potential for confounding due to ill
health. In a large sample drawn from the Swedish population register, high offspring BMI was
associated with increased risk of CVD, diabetes and some cancers, but low offspring BMI was
not associated with increased risk of respiratory disease and lung cancer.[30] Mendelian ran-
domization studies using multiple genetic instruments for BMI and methods for handling
non-linearity would help to bring clarity to the association of low BMI with disease.
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Limitations
Data are drawn from an elderly population of mainly white British women. Consistent with
other sources, BMI greater than 25kg/m2 in this population is high, at almost four-fifths.[32]
However, rates of obesity have been increasing rapidly in recent years in the UK;[32] therefore
this population of elderly women who lived the majority of their lives in a lower obesity setting
may not reflect more contemporary British populations. Replication of results in other popula-
tions is therefore needed. 22kg/m2 was chosen as the cut-point for the category of women with
lowest BMI on the basis of prior evidence from the Prospective Studies Collaboration.[2] How-
ever, choice of cut-points may influence results and appropriate cut-points may vary between
different populations. BWHHS women have relatively low prevalence of smoking and physical
activity (when housework is excluded).[33, 34] It is possible that differential associations ac-
cording to anthropometric measure may be more marked in younger populations and those
with higher background rates of smoking.
Conclusions
Women with low BMI have a detrimental profile of health makers compared to women with
lowWHR. Unlike BMI, we find women who have extremely lowWHR do not appear to have
an elevated risk of COPD, lending some support to the hypothesis that WHR is a less con-
founded measure of adiposity than BMI. Results suggest conventional epidemiological studies
seeking to reveal the true association between adiposity and disease outcome may be unable to
adequately remove the effects of residual confounding or reverse causality.
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